113 related articles for article (PubMed ID: 21480107)
1. Responsiveness of children with celiac disease to different hepatitis B vaccination protocols.
Balamtekın N; Uslu N; Baysoy G; Saltik-Temızel I; Demır H; Yüce A
Turk J Gastroenterol; 2011 Feb; 22(1):27-31. PubMed ID: 21480107
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
[TBL] [Abstract][Full Text] [Related]
3. Role of gluten intake at the time of hepatitis B virus vaccination in the immune response of celiac patients.
Zingone F; Capone P; Tortora R; Rispo A; Morisco F; Caporaso N; Imperatore N; De Stefano G; Iovino P; Ciacci C
Clin Vaccine Immunol; 2013 May; 20(5):660-2. PubMed ID: 23446217
[TBL] [Abstract][Full Text] [Related]
4. The response to hepatitis B vaccine: does it differ in celiac disease?
Ertem D; Gonen I; Tanidir C; Ugras M; Yildiz A; Pehlivanoğlu E; Eksioglu-Demiralp E
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):787-93. PubMed ID: 19584738
[TBL] [Abstract][Full Text] [Related]
5. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
[TBL] [Abstract][Full Text] [Related]
6. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
7. [Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer].
Villena R; Zubieta M; Hurtado C; Salgado C; Silva G; Fernández J; Villarroel M; Fernández M; Brahm J; O'Ryan M; Santolaya ME
Rev Chil Pediatr; 2015; 86(4):236-43. PubMed ID: 26298296
[TBL] [Abstract][Full Text] [Related]
8. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
[TBL] [Abstract][Full Text] [Related]
9. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
[TBL] [Abstract][Full Text] [Related]
10. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.
Vitaliti G; Praticò AD; Cimino C; Di Dio G; Lionetti E; La Rosa M; Leonardi S
World J Gastroenterol; 2013 Feb; 19(6):838-45. PubMed ID: 23430309
[TBL] [Abstract][Full Text] [Related]
12. Duration of protection after infant hepatitis B vaccination series.
Middleman AB; Baker CJ; Kozinetz CA; Kamili S; Nguyen C; Hu DJ; Spradling PR
Pediatrics; 2014 Jun; 133(6):e1500-7. PubMed ID: 24843060
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up].
Zhang L; Zhang W; Lyu JJ; Zhang JJ; Liu JY; Yan BY; Feng Y; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1156-1160. PubMed ID: 28910922
[No Abstract] [Full Text] [Related]
15. [A study on immune efficacy in children immunized by hepatitis B vaccine in disease surveillance points of Fujian].
Li L; Zhou Y; Zhao L; Xia S; Wang Z
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):372-4. PubMed ID: 15617252
[TBL] [Abstract][Full Text] [Related]
16. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
17. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
[No Abstract] [Full Text] [Related]
18. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
[TBL] [Abstract][Full Text] [Related]
19. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
Krairittichai U; Sethakarun S
J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
